NVE Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVEC research report →
Price Chart
About the company
NVE Corporation develops and sells devices that use spintronics, a nanotechnology relying on electron spin to acquire, store, and transmit information, both in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in sensing and transmitting data. Its products include standard sensors designed to detect the presence of magnetic or metallic materials, which help determine position, rotation, or speed in the factory automation market.
- CEO
- Peter G. Eames
- IPO
- 1995
- Employees
- 41
- HQ
- Eden Prairie, MN, US
Get TickerSpark's AI analysis on NVEC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $339.28M
- P/E
- 21.30
- PEG
- 0.71
- P/S
- 12.42
- P/B
- 6.58
- EV/EBITDA
- 17.96
- Div Yield
- 5.08%
- Gross Margin
- 79.27%
- Op Margin
- 61.63%
- Net Margin
- 58.15%
- ROE
- 30.52%
- ROIC
- 27.70%
Latest fiscal year · YoY change
- Revenue
- $26.33M+1.8%
- Gross Profit
- $20.73M-4.2%
- Op Income
- $15.92M
- Net Income
- $15.20M+0.9%
- EPS
- $3.14+0.6%
- OCF Growth
- +16.4%
- FCF Growth
- +10.8%
- 52W High
- $135.00
- 52W Low
- $57.22
- 50D MA
- $94.56
- 200D MA
- $91.21
- Beta
- 1.35
- RSI (14)
- 42
- Avg Volume
- 113.31K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
NVE reported a solid quarter with revenue down modestly year over year, but strong distributor-sales growth, high margins, and upbeat commentary on robotics and power-conversion opportunities.· October 21, 2026
- Quarterly revenue fell 8% year over year, mainly from a 9% drop in product sales and a 95% decline in defense product sales, partly offset by 25% growth in contract R&D.
- Net income was $3.17 million, or $0.65 per diluted share, versus $3.3 million, or $0.68 per share, a year ago; gross margin was 78% and net margin was 54%.
- Distributor sales rose 67% year over year in the quarter, with management saying demand strengthened for both new and legacy commercial products.
- Management said the medical-device order disruption was temporary and expects medical and defense sales to recover in the current quarter.
- The company highlighted new wafer-level chip-scale sensors and gear sensors aimed at robotics, factory automation, and humanoid robotics, with early design wins and strong customer interest.
Total revenue for the quarter decreased 8% year over year. The decline was driven by a 9% decrease in product sales, partly offset by a 25% increase in contract R&D revenue. Net income was $3.17 million, or $0.65 per diluted share, versus $3.3 million, or $0.68 per diluted share, in the prior-year quarter. Gross margin was 78%; operating margin was 55%; pretax margin was 63%; and net margin was 54%. For the first 6 months of fiscal 2027, revenue was $16.9 million, up 36%, and net income was $9.57 million, or $1.97 per diluted share. Cash from operations was $11.1 million for the first half, and cash plus marketable securities rose from $43.5 million to $44.4 million. Looking ahead, management expects medical-device and defense sales to recover in the current quarter, and said revenues in the second half of the fiscal year should be consistent with the first half. The effective tax rate is expected to remain between 14% and 16% for at least the remainder of the fiscal year.
Peter Eames framed the quarter as part of a longer-term transition toward higher-growth end markets, especially robotics, automation, data centers, and power conversion. He emphasized new product launches, including the smallest sensor NVE has made and a new family of gear sensors for precision motion applications, and said the company is seeing strong interest and early design wins. His tone was constructive and confident, with repeated references to long-term growth, expanded capacity, and opportunities created by the recent leadership transition and board expansion.
Daniel Nelson said the quarter’s revenue decline was mainly due to a short-term inventory adjustment at one large medical-device customer and a steep drop in defense product sales, which he described as highly variable because of procurement cycles. He noted SG&A rose 44% while R&D fell 17%, and said the effective tax rate dropped to 14% from 20% due to favorable tax law changes; he expects the tax rate to stay in the 14% to 16% range for the rest of the fiscal year. He also pointed to strong cash generation: operating cash flow of $11.1 million in the first half, cash and marketable securities of $44.4 million, and dividends of $1.00 per share paid in the quarter with another dividend declared for late November.
Analysts focused on whether the order shortfall was merely pushed into later periods, and management said the variability was mainly from orders pulled into Q1 from Q2, with no further disruptions expected. Multiple questions centered on robotics and power conversion, where management said growth is strong, new products are seeing positive feedback, and humanoid robotics could use several NVE sensors per robot, with ASPs of about $1 to $2 per sensor. Analysts also asked about backlog, customer concentration, and capacity; management said it does not track backlog, expects more revenue from new customers, and said capacity expansion is shifting gradually from R&D toward production as demand builds.
The call showed clear momentum in distributor sales, up 67% year over year in the quarter, and management said growth is coming from both legacy and new products. New sensors targeted at robotics and power conversion appear to be getting early design wins, and management sounded optimistic that these markets can drive larger orders over time. Cash remains solid, margins are high, and the company is still paying a $1.00 quarterly dividend.
Quarterly revenue still declined 8% year over year, and the business remains exposed to customer timing, especially in medical devices and defense, which management described as volatile. The quarter’s mix also included lower direct customer sales and a large SG&A increase from stock-based compensation tied to higher director option grant prices. Management’s growth thesis is still early-stage for new products, with many orders starting as samples or low-thousand-unit purchases that may take quarters to scale.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.6%
- Shares Outstanding
- 4.84M
- Float Shares
- 4.82M
of shares held by institutions
136 13F filers
Buy/sell ratio 0.61. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Penserra Capital Management LLC | 635.27K | ▲ 54.77K |
| Defiance Etfs, LLC | 621.19K | ▼ 14.08K |
| Blackrock, Inc. | 437.35K | ▲ 13.80K |
| Vanguard Group Inc | 404.28K | ▼ 69 |
| State Street Corp | 371.23K | ▼ 3.81K |
| Vanguard Capital Management LLC | 212.32K | ▼ 3.29K |
| Vanguard Portfolio Management LLC | 204.25K | ▲ 8.78K |
| Geode Capital Management, LLC | 175.71K | ▲ 18.60K |
| Renaissance Technologies LLC | 173.34K | ▲ 2.61K |
| Dimensional Fund Advisors LP | 100.57K | ▼ 8.44K |
| Punch & Associates Investment Management, Inc. | 75.51K | ▼ 5.71K |
| Morgan Stanley | 74.58K | ▼ 781 |
Held by 180 ETFs
Biggest fund positions in NVEC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 26, 26 | BRACKE JAMES W | other | 400 |
| Oct 26, 26 | BRACKE JAMES W | other | 400 |
| Sep 8, 26 | BAKER DANIEL A | sell | 2,000 |
| Sep 8, 26 | BAKER DANIEL A | sell | 19,140 |
| Aug 25, 26 | BAKER DANIEL A | sell | 1,731 |
| Aug 27, 26 | BAKER DANIEL A | sell | 2,000 |
| Aug 27, 26 | BAKER DANIEL A | sell | 2,000 |
| Aug 12, 26 | Wei Xuan Kelly | sell | 538 |
| Aug 17, 26 | BAKER DANIEL A | sell | 1,500 |
| Aug 6, 26 | Valentine Carolyn Walker | other | 1,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NVEC coverage
Recent articles, reports, and earnings notes.
No research on NVEC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NVEC report →NVE Corp. Investors with Losses Should Contact Block & Leviton LLP
newsfilecorp.com · Nov 20
NVE Corporation (NVEC) Faces Investor Scrutiny Amid Revenue Pull-Forward- HBSS
prnewswire.com · Nov 19
NVE Corporation Investor News: If You Have Suffered Losses in NVE Corporation (NASDAQ: NVEC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com · Nov 18
Bragar Eagel & Squire, P.C. is Investigating NVE Corporation on Behalf of NVE Stockholders and Encourages Investors to Contact the Firm
globenewswire.com · Nov 17
ROSEN, A LONGSTANDING LAW FIRM, Encourages NVE Corporation Investors to Inquire About Securities Class Action Investigation - NVEC
newsfilecorp.com · Nov 16
NVE Corporation Investor News: If You Have Suffered Losses in NVE Corporation (NASDAQ: NVEC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com · Nov 15
ROSEN, LEADING INVESTOR COUNSEL, Encourages NVE Corporation Investors to Inquire About Securities Class Action Investigation - NVEC
newsfilecorp.com · Nov 14
ROSEN, A LONGSTANDING LAW FIRM, Encourages NVE Corporation Investors to Inquire About Securities Class Action Investigation - NVEC
newsfilecorp.com · Nov 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.